Form 4 for GPCR Structure Therapeutics Inc.
Accepted 2024-06-05 00:00:00 ET · period of report 2024-06-03 · accession 0001415889-24-015683 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-05 | 2024-06-03 | GPCR | Lin Xichen | CSO | M - OptEx | $0.34 | +106.2K | 191.9K | +124% | +$36.1K |
| D | 2024-06-05 | 2024-06-03 | GPCR | Lin Xichen | CSO | C - Cnv Deriv | $0.00 | -106.2K | 85.7K | -55% | $0 |
| D | 2024-06-05 | 2024-06-03 | GPCR | Lin Xichen | CSO | C - Cnv Deriv | $0.00 | +35.4K | 35.4K | New | $0 |
| D | 2024-06-05 | 2024-06-03 | GPCR | Lin Xichen | CSO | M - OptEx | $0.00 | -106.2K | 213.8K | -33% | $0 |
| DM | 2024-06-05 | 2024-06-03 | GPCR | Lin Xichen | CSO | S - Sale | $47.50 | -35.4K | 0 | -100% | -$1.68M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2024-06-03 | M | A | 106,200 | $0.34 | 191,907 | D | — | — | |
| 2 | Common | Ordinary Shares | 2024-06-03 | C | D | 106,200 | $0.00 | 85,707 | D | — | — | (F1) The Ordinary Shares were converted into American Depositary Shares as reported in Table II above. |
| 3 | Derivative | American Depositary Shares | 2024-06-03 | C | A | 35,400 | $0.00 | 35,400 | D | — · — to — | 106,200 Ordinary Shares | (F5) 106,200 Ordinary Shares, which were acquired upon exercise of a share option, were converted into 35,400 American Depositary Shares. (F4) Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. |
| 4 | Derivative | Share Option (right to buy) | 2024-06-03 | M | D | 106,200 | $0.00 | 213,800 | D | $0.34 · — to 2029-09-10 | 106,200 Ordinary Shares | (F3) This reflects the number of Ordinary Shares remaining under the share option following the partial exercise of the share option for 106,200 Ordinary Shares. (F2) 1/4 of the shares vested one year after July 22, 2019 (the "Vesting Commencement Date"); the balance of the shares vested in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date. |
| 5 | Derivative | American Depositary Shares | 2024-06-03 | S | D | 17,700 | $45.00 | 17,700 | D | — · — to — | 53,100 Ordinary Shares | (F6) The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on December 28, 2023. (F4) Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. |
| 6 | Derivative | American Depositary Shares | 2024-06-03 | S | D | 17,700 | $50.00 | 0 | D | — · — to — | 53,100 Ordinary Shares | (F6) The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on December 28, 2023. (F7) The weighted average sale price for the transaction reported was $50.004, and the range of prices were between $50.00 and $50.16. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided. (F4) Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. |